Nighthawk remains jolly 09/02/2012
US-focused Nighthawk Energy is launching a $7.5 million program to invest in its Colorado-based Jolly Ranch project.
US pharmaceutical group Cephalon is to pay drug discoverer ImmuPharma £10 million upfront for an option on its Lupuzor lupus treatment.
The option deal gives Cephalon the right to obtain an exclusive worldwide licence for Lupuzor, which treats Lupus Erythematosus, a chronic auto-immune disease that damages skin, joints, blood vessels and the nervous system. If the US company exercises this option, it will then pay AIM-quoted ImmuPharma a one-time licence fee, payments if Lupuzor passes necessary regulatory milestones up to a maximum of £330 million and royalties on subsequent commercial sales.
ImmuPharma, which lost £1.5 million in the first half of this year, is now conducting a Phase IIb study of Lupuzor on patients in Europe and Latin America. If Cephalon exercises its option, it will take on all expenses for Phase III studies and commercialisation of the product.
Dimitri Dimitriou, chief executive officer of London-based ImmuPharma, proclaims this agreement ‘secures the future for our most advanced asset’. After a rough ride, ImmuPharma shares, which fell from 84.5p in early 2007 to 36.5p earlier this month, have bounced to 56.5p and should recover further if Lupuzor makes progress.
Growth Company Investor subscribers have full access to all our AIM and small-cap share recommendations. To subscribe today with a half-price offer, and gain immediate access to all the recommendations, click here.
Subscribe today and save 50%. Receive company watch recommendations and extensive company profile tips, released two months ahead of the market.
Advertisement
£100 credit when you open five trades within 60 days – terms apply. Spread Trading is not for everyone please ensure you understand the risks as you may lose more than your initial deposit. Click here for more information.
This unique study analyses the shareholdings of companies listed on AIM, extracting trends including rankings of the value and number of their investments.
Please click here to order your copy of the report or call 0207 250 7056.
Informative features and research on fast-growing companies, small-cap and growth stocks, penny shares, stock market tips and share recommendations, directors' dealings, company news and analysis, new issues and upcoming IPOs.
If you're interested in business tax updates visit our specialist tax guide website.
Daily coverage of small-cap company stocks on London's junior markets AIM and PLUS, breaking news, stock research and latest share price information for investors. Full sector coverage with all the latest news on smaller listed companies, updated several times a day with financial reports, trading statements and links to further web resources.
Advertisement
US-focused Nighthawk Energy is launching a $7.5 million program to invest in its Colorado-based Jolly Ranch project.
Africa-focused Tower Resources (TRP) has raised £5.4 million via a placing with a mixture of institutional investors and directors.
Beleaguered travel operator Thomas Cook (TCG) has reported a loss of £91 million its first quarter also announcing the sale of its Indian division.
AIM-quoted Chariot Oil and Gas (CHAR) has completed a 3D seismic survey across its central blocks.
Aminex (AEX) and Solo Oil (SOLO) both reported the Ntorya-1 well had 'not encountered' sandstone intervals after drilling 2500 metres.
Brady (BRY), the supplier of software to the commodities sector, is to raise £18 million to fund two acquisitions.